GNPNAT1 was only reported in prostate cancer, which was suggested to be over-expressed in prostate cancer tissue (Ren et al., 2016) and to be connected with the development of castrationresistant prostate cancer (Kaushik et al., 2016). The gene discussed is GNPNAT1; the disease is prostate carcinoma.